Steven Nickle, DO
Dermatology · Layton, UTNPI 1255722617
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.1%), consulting fees and education — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by UCB, Inc. at 31.7% of the total.
Across 437 payments — averaging $25.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$4K
- Novartis$3K
- AbbVie$1K
- Sun Pharmaceutical Industries Inc.$788
- Johnson & Johnson$484
- Sanofi$298
- plus $2K from 18 others
What the payments were for
- Consulting fees$4,90044%
- Food & beverage$5,84252%
- Education$4744%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 10 | $3,554 |
| Novartis | 63 | $2,523 |
| AbbVie | 146 | $1,471 |
| Sun Pharmaceutical Industries Inc. | 59 | $788 |
| Johnson & Johnson | 11 | $484 |
| Sanofi | 20 | $298 |
| Pfizer | 20 | $278 |
| Lilly USA, LLC | 15 | $273 |
| LEO Pharma Inc. | 9 | $226 |
| Galderma Laboratories, L.p. | 13 | $220 |
| Arcutis Biotherapeutics, Inc. | 18 | $196 |
| E.r. Squibb & Sons, L.L.C. | 9 | $150 |
| Biofrontera Inc. | 7 | $149 |
| Sanofi-aventis U.S. LLC | 4 | $141 |
| Regeneron Healthcare Solutions, Inc. | 5 | $86 |
| Amgen | 5 | $84 |
| Organon | 10 | $76 |
| Dermavant Sciences, Inc. | 4 | $71 |
| Incyte Corporation | 3 | $43 |
| Dermira, Inc. | 2 | $30 |
| Almirall LLC | 1 | $30 |
| Botanix SB Inc | 1 | $18 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $16 |
| Boehringer Ingelheim | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Bimzelx$3,250
How this compares
$11,216 in reported general payments places this provider in the 85th percentile of 163 dermatology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 17 | $235,818 |
| Clobetasol Propionate | 93 | $3,619 |
| Triamcinolone Acetonide | 110 | $1,184 |
| Mupirocin | 49 | $673 |
| Spironolactone | 50 | $596 |
| Ketoconazole | 27 | $546 |
| Doxycycline Monohydrate | 16 | $453 |
| Hydrocortisone | 25 | $369 |
| Doxepin Hcl | 19 | $255 |
| Doxycycline Hyclate | 15 | $217 |
| Hydroxychloroquine Sulfate | 14 | $203 |
| Finasteride | 54 | $190 |
| Prednisone | 12 | $32 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Layton
- Matthew InnesLayton$6K
- Jamison HarveyLayton$5K
- Michael MartineauLayton$3K
- Bradley NeuenschwanderLayton$3K
- Brayden ForbesLayton$2K
- Scott CheckettsLayton$2K
- Brian WilliamsMidvale$876K
- Travis JamesProvidence$437K
- Jason HadleyBountiful$294K
- Doug Lass ForshaWest Jordan$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.